Wolff & Samson PC 1 Boland Dr The Offices At Crystal Lake, West Orange, NJ 07052 9735302009 (Office), 9735302209 (Fax) Wolff & Samson PC The Offices At Crystal Lake One Boland Drive, West Orange, NJ 07052 9735302009 (Office), 9735302209 (Fax)
Licenses:
New Jersey - Active 1973
Education:
Rutgers School of Law Degree - JD - Juris Doctor - Law Graduated - 1973 Rutgers University Degree - BA - Bachelor of Arts Graduated - 1970
Specialties:
Health Care - 34% Corporate / Incorporation - 33% Securities / Investment Fraud - 33%
Associations:
American Bar Association - Member American Health Lawyers Association - Member Essex County Bar Association - Member New Jersey State Bar Association - Member
Improving Healthcare: A Dose of Competition a Report by the Federal Trade Commission and the Department of Justice (July, 2004), with Various Supplementary Materials
This application provides methods of treating cancer and/or inhibiting angiogenesis with an anti-Ang2 antibody or functional part thereof either alone or in combination with at least one additional therapeutic agent.
Monitoring Treatment Of Histiocytosis With Vemurafenib And Dabrafenib
- San Diego CA, US Elie L. Diamond - New York NY, US David M. Hyman - New York NY, US Filip Janku - Houston TX, US Mark G. Erlander - Carlsbad CA, US Cecile Rose T. Vibat - San Diego CA, US
International Classification:
C12Q 1/68 A61K 31/506 A61K 31/437
Abstract:
Provided are methods of determining the amount of a BRAF V600E mutation over time in a subject with Langerhans Cell Histiocytosis (LCH) or Erdheim-Chester Disease (ECD) who is being treated with vemurafenib or dabrafenib.
Detecting And Monitoring Mutations In Histiocytosis
- San Diego CA, US Mark G. Erlander - Carlsbad CA, US Cecile Rose Vibat - San Diego CA, US Karena Kosco - Carlsbad CA, US Abdel-Wahab Omar - New York NY, US Eli L. Diamond - New York NY, US David M. Hyman - New York NY, US
International Classification:
C12Q 1/68
US Classification:
424 852, 514300, 435 612, 435 611, 506 2
Abstract:
Provided is methods of detecting a mutation in a histiocytosis patient. Also provided is methods of selecting and/or applying treatment or therapy for a histiocytosis patient. Further provided is a method of treating a patient having a histiocytosis.
License Records
David S. Hyman
Address:
2702 Taney Rd, Baltimore, MD
License #:
9558 - Expired
Category:
Architect
Issued Date:
Apr 15, 1983
Expiration Date:
Feb 28, 1991
David Solomon Hyman
Address:
Baltimore, MD 21209
License #:
RA008120B - Expired
Category:
Architects
Type:
Registered Architect
Name / Title
Company / Classification
Phones & Addresses
David M. Hyman Partner
P C Gibbons Pac Inc Legal Services Office
1 Gtwy Ctr, Newark, NJ 07102 9735964500
David Hyman Manager
Hotel Metro Hotels & Motels, Except Casino Hotels
45 W 35 St, New York, NY 10001 2129472501, 2122791310
David Hyman Director, Secretary, Treasurer
Integrated Sun Management, Inc
923 Levering Ave, Los Angeles, CA 90024 142 Tewkesbury Rd, Scarsdale, NY 10583 10 Ponte, Irvine, CA 92606
David A Hyman
HYMAN AND HYMANM LTD
David Michael Hyman
David Hyman MD Internist
505 E 70 St, New York, NY 10021 2127469663
David S Hyman
DSH DIAMOND CORP Jewelry Stores
649 2 Ave #3D, New York, NY 10036 55 W 47 St #810, New York, NY 10036 2123912161
David Hyman Finance Manager
Spa LLC Investor · Physical Fitness Facility
3 Ann St, Verona, NJ 07044
David Hyman Ofm
Holy Name College College/University
1650 Saint Camillus Dr, Silver Spring, MD 20903 3014343400
Medicine Doctors
Dr. David M Hyman, New York NY - MD (Doctor of Medicine)
1275 York Ave, New York, NY 10065 2126392000 (Phone), 6468884586 (Fax)
525 E 68Th St, New York, NY 10065
NEW YORK PRESBYTERIAN HOSPITAL 525 E 68Th St Suite K427, New York, NY 10065 2127464655 (Phone), 2127468451 (Fax)
Certifications:
Internal Medicine, 2009 Medical Oncology, 2012
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
1275 York Ave, New York, NY 10065
525 E 68Th St, New York, NY 10065
NEW YORK PRESBYTERIAN HOSPITAL 525 E 68Th St Suite K427, New York, NY 10065
Memorial Sloan - Kettering Cancer Center 1275 York Avenue, New York, NY 10065
Education:
Medical School University of Medicine And Dentistry of New Jersey / Newark Graduated: 1992 Medical School Weill Cornell Medical College Graduated: 2006
Memorial Sloan Kettering Cancer Center 1275 York Ave, New York, NY 10065 6468882317 (phone), 6468884586 (fax)
Education:
Medical School Cornell University Weill Medical College Graduated: 2006
Conditions:
Acute Renal Failure Constipation Intestinal Obstruction Malignant Neoplasm of Female Breast Pulmonary Embolism
Languages:
English
Description:
Dr. Hyman graduated from the Cornell University Weill Medical College in 2006. He works in New York, NY and specializes in Medical Oncology. Dr. Hyman is affiliated with Memorial Sloan Kettering Cancer Center.
American Board of Internal Medicine Certification in Internal Medicine American Board of Internal Medicine Sub-certificate in Oncology (Internal Medicine)
I have been involved with the promotional product industry since 1985. I just recently revamped my company to now include a printing division as well as a lapel... I have been involved with the promotional product industry since 1985. I just recently revamped my company to now include a printing division as well as a lapel pin division.
Joan Bourget, John Smith, Kim Tran, Seth Lebeau, Eric Macksoud, Mike Rocha, Kathryn Orourke, Ashley Vasques, Laura Dibon, Stephan Kozaczka, Alyssa Sroka, Matthew Frazier
Unagi founder and CEO David Hyman said the idea was to help Google employees get to work or even just to the closest bus stop. (Google famously provides free shuttle bus service to its employees in Silicon Valley.)
Date: Apr 04, 2022
Category: Business
Source: Google
Netflix CEO Reed Hastings, Content Chief Ted Sarandos to See Pay Hiked to $31.5 Million in 2019
base salary of $3.5 million and stock worth $2.8 million (a 20% year-over-year increase). In August, Netflix said Wells will exit the company after his successor is hired. Netflix general counsel David Hyman will have a 2019 salary of $3.5 million and $3.85 million in stock options (up 27% from 2018).
Date: Dec 28, 2018
Category: Headlines
Source: Google
Prepping for FDA filing, Loxo rolls up data on its site-agnostic cancer med larotrectinib
[T]he larotrectinib TRK fusion story fulfills the promise of precision medicine, where tumor genetics rather than tumor site of origin define the treatment approach," said David Hyman, lead investigator in the Navigate trial and chief of the early drug development service at Memorial Sloan Ketterin
Date: Jun 03, 2017
Category: Business
Source: Google
ASCO17: Loxo shows promise of biomarker approach to cancer
"These findings embody the original promise of precision oncology: treating a patient based on the type of mutation, regardless of where the cancer originated," said David Hyman, the lead study author and head of early drug development at Memorial Sloan Kettering Cancer Center.
Date: Jun 03, 2017
Category: Business
Source: Google
Larotrectinib May Provide Durable Efficacy Across Many Tumor Types
This is the first definitive study to evaluate the efficacy of a TRK inhibitor in a broad range of TRK fusionpositive cancers, said lead study author David Hyman, MD, chief of early drug development at Memorial Sloan Kettering Cancer Center in New York.
locations showed that by far the most frequent responses were seen in breast cancer. However, SUMMIT's principal investigator David Hyman argued at the AACR meeting that the higher response rate in breast cancer was partly due to more clinical experience with how to use the drug in its flagship indication.
Date: May 24, 2017
Category: Health
Source: Google
'O.J. Made in America' Wins Producers Guild's Documentary Movie Award
Veep(Season 5)Producers: David Mandel, Frank Rich, Julia Louis-Dreyfus, Lew Morton, Morgan Sackett, Sean Gray, Peter Huyck, Alex Gregory, Jim Margolis, Georgia Pritchett, Will Smith, Chris Addison, Rachel Axler, David Hyman, Erik Kenward, Billy Kimball, Steve Koren
This new study shows the potential power of precision medicine, if a specific drug is available to treat a specific cancer, said Dr. David Hyman, a medical oncologist and director of developmental therapeutics at Memorial Sloan Kettering Cancer Center in New York City.